检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

O7-3 Phase II study of brigatinib in patients with TKI-naive ROS1-rearranged non-small cell lung cancer (NSCLC): Barossa study

Toshiaki Takahashi,Seiji Niho,Ryo Toyozawa,Yasushi Goto,Kadoaki Ohashi,Haruko Daga,Hiroshi Tanaka,Yoshihiro Hattori,Masahiro Morise,Jun Sakakibara-Konishi,Masahiro Kodani,Takaya Ikeda,Shingo Matsumoto,Kiyotaka Yoh,Shogo Nomura,Koichi Goto

Annals of Oncology（2023）

引用 0|浏览5
暂无评分
关键词
cell lung cancer,lung cancer,brigatinib,tki-naive,non-small
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要